Daewoong Pharmaceutical Revenue

In the year 2025, Daewoong Pharmaceutical had annual revenue of 1.57T KRW with 10.42% growth. Daewoong Pharmaceutical had revenue of 397.12B in the quarter ending December 31, 2025, with 7.95% growth.

Revenue

1,570.89B

Revenue Growth

+10.42%

P/S Ratio

1.11

Revenue / Employee

955.53M

Employees

1,644

Market Cap

1,747.80B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1,570.89B	148.21B	10.42%
Dec 31, 2024	1,422.68B	47.35B	3.44%
Dec 31, 2023	1,375.33B	95.24B	7.44%
Dec 31, 2022	1,280.09B	127.12B	11.03%
Dec 31, 2021	1,152.98B	97.55B	9.24%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
GC Biopharma	1,991.28B
Celltrion Pharm	274.73B
Chong Kun Dang Pharmaceutical	1,692.40B
Hanall Biopharma	155.18B
DongKook Pharmaceutical	926.88B
Daewoong	2,068.37B
Ildong Pharmaceutical	566.93B
Boryung	1,017.43B

Revenue Rankings

Daewoong Pharmaceutical News

1 year ago - Sun Pharma launches FEXUCLUE 40 mg in India for treatment of Erosive Esophagitis - Business Upturn

More News